J&J Quality Issues, Hill Concerns Spill Over To Blacksmith's PediaCare
This article was originally published in The Tan Sheet
Executive Summary
The impact of McNeil Consumer Healthcare's quality control lapses extends to Blacksmith Brands, which becomes a congressional inquiry target after recalling PediaCare products manufactured at one of the Johnson & Johnson subsidiary's plants
You may also be interested in...
Prestige Brands’ OTC Revenue Climbs With Boost In Advertising
Prestige CEO Mannelly attributes the success of Clear Eyes, Chloraseptic, Compound W and Little Remedies to a $1 million increase in advertising and promotions. The OTC division’s net revenue soar 55.7% to $79.2 million.
Prestige Brands’ OTC Revenue Climbs With Boost In Advertising
Prestige CEO Mannelly attributes the success of Clear Eyes, Chloraseptic, Compound W and Little Remedies to a $1 million increase in advertising and promotions. The OTC division’s net revenue soar 55.7% to $79.2 million.
Prestige CEO Mannelly Sees Change In Retail "Headwinds" Giving Brands More Shelf Space
In a year-and-a-half of heading Prestige Brands Holdings, Matthew Mannelly has been a change agent for the consumer health products firm.